Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Regado Biosciences Inc.

Division of Allergan PLC
www.regadobiosciences.com

Latest From Regado Biosciences Inc.

Dong-A Eyes Expanded Evogliptin Markets Via Tobira NASH Deal

Dong-A ST’s in-house developed DPP-4 inhibitor evogliptin is set to enter major markets, including the US and Europe, through a new licensing deal with Tobira that will focus on the treatment of non-alcoholic steatohepatitis (NASH) rather than diabetes.

BioPharmaceutical Asia Pacific

Intercept’s Phase III Endpoints May Not Apply To Other Firms’ NASH Programs

Tobira’s cenicriviroc, which addresses both fibrosis and the inflammation underlying both NASH and fatty liver disease, could be approvable on a different set of parameters than Intercept’s OCA, the company says.

BioPharmaceutical Clinical Trials

NASH Opportunity Spurs Deal-Making Flurry

Companies big and small are making deals and advancing candidates to address an unmet medical need thought to have a vast undiagnosed patient base in the U.S. and Europe.

BioPharmaceutical Deals

Deals Shaping The Medical Industry, February 2015

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, Pharmaceuticals, and Research/Analytical – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced December 2014-January 2015.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Biotechnology
    • Antisense, Oligonucleotides
    • Large Molecule
  • Pharmaceuticals
  • Therapeutic Areas
  • Blood & Coagulation Disorders & Products
  • Cardiovascular
  • Alias(es)
  • Quartet Biosciences Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Allergan PLC
  • Senior Management
  • Chris Rusconi, PhD, SVP, Disc. & Preclin. Dev., CSO
  • Contact Info
  • Regado Biosciences Inc.
    Phone: (908) 580-2100
    106 Allen Rd.
    Basking Ridge, NJ 07920
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register